论文部分内容阅读
Objective The aim of this study was to develop suitable adjuvants for Mycoplasma hyopneumoniae vaccine strain 168 and provide effective protection after intramuscular inoculation.Methods Different adjuvant components were screened to assess their toxicity against the live vaccine and their ability to activate PBMC cells, and various adjuvant formulations were then designed and prepared.